Celltrion Petition For Review Of Growth Factor Trap Patent Granted
ALEXANDRIA, Va. — The Patent Trial and Appeal Board on July 20 instituted inter partes review of a Regeneron Pharmaceuticals Inc. patent directed to a vascular endothelial growth factor (VEGF) antagonist,...To view the full article, register now.
Already a subscriber? Click here to view full article